La description :almac group - partnering to advance human health. providing a range of contract pharmaceutical development and manufacturing services globally....
Classement Alexa Global: # 479,524,Alexa Classement dans United States est # 219,099
Server:Apache...
L'adresse IP principale: 5.39.40.91,Votre serveur France,Roubaix
ISP:OVH SAS TLD:com Code postal:fr
Ce rapport est mis à jour en 25-Jul-2018
Created Date:
2006-02-27
Changed Date:
2016-12-29
Données techniques du almacgroup.com
Geo IP vous fournit comme la latitude, la longitude et l'ISP (Internet Service Provider) etc. informations.
Notre service GeoIP a trouvé l'hôte almacgroup.com.Actuellement, hébergé dans France et son fournisseur de services est OVH SAS .
Les informations d'en-tête HTTP font partie du protocole HTTP que le navigateur d'un utilisateur envoie à appelé Apache contenant les détails de ce que le navigateur veut et acceptera de nouveau du serveur Web.
MX preference = 8, mail exchanger = so-svc-ftm1.almacgroup.com. MX preference = 8, mail exchanger = cr-svc-ftm1.almacgroup.com.
HtmlToText
partnering to advance human health -- about us careers contact us client login search search menu general about about us almac history, culture and values company overview video ethical statement leadership core values & vision our history awards almac awards awards archive sir allen mcclay tax strategy: almac approach our locations careers almac careers careers overview graduate careers why choose an apprenticeship at almac? experienced professionals economy & cost of living schools, outreach and undergraduates for parents & students for teachers sloane mcclay award uk and row careers us careers applying working at almac why we are different training, learning & development staff recognition health & wellness our locations living in northern ireland overview economy & cost of living education & healthcare almac employee relocation testimonials our exceptional culture our exceptional people our exceptional stories contact us contact us talent network news events knowledge centre contact us client login client login almac returns waybill generator newsletter signup company information terms and conditions privacy & cookie policy discovery about us overview meet the team case studies – our people our research research overview ubiquitin specific proteases overview protein-drug conjugates partnerships & collaborations pipeline pipeline overview alm201 wee-1 ubiquitin specific protease platform protein-drug conjugates news & events news events working at almac discovery working at almac discovery contact us contact almac discovery diagnostics go to diagnostics clinical trial solutions our clinical trial solutions biomarker discovery ruo assay development clinical trial assay development cdx development and commercialisation customised cdx clinical testing supporting services regulatory and quality proficiency bioinformatics and biostatistics excellence project management expertise global laboratories our global laboratories platforms & technologies supporting lab services panels and assays dna panel solution rna panel solution assay development pipeline assay development pipeline overview i-o angio ddrd emt prostate dx coldx resources, news & events news upcoming events publications articles posters videos webinars technical sheets almac voice about diagnostics about almac diagnostics meet the team our history the almac group working at diagnostics our culture why almac diagnostics? a day in the life current vacancies contact us contact diagnostics our laboratories api services & chemical development about api services & chemical development api development & manufacture api development and manufacture overview api development and manufacture – early phase api development and manufacture – early phase highly potent manufacture api manufacturing facilities api development and manufacture – late phase api development and manufacture – late phase overview highly potent api manufacture antibody (or protein) drug conjugates (adcs) api manufacturing facilities 14c radiolabelling 14c radiolabelling overview biocatalysis solutions biocatalysis solutions overview: selectazyme™ enzyme panel quotation request enzyme screening biotransformation process development enzyme evolution fermentation development metabolites enzyme screening kits – selectazyme™ peptide & protein technology peptide and protein technology overview custom peptide synthesis for research use custom peptide synthesis for research use overview chemokines & complement proteins human native chemokines human site-specifically biotin labelled chemokines site-specific af647® labelled chemokines modified histones ubiquitylated peptides peptide conjugation gmp peptide manufacture – early phase gmp peptide manufacture – early phase overview reference standard preparation and characterisation physical chemistry studies in support of preformulation development peptide vaccine cocktails highly potent peptide manufacture gmp peptide manufacture – late phase flexyte® fluorescence lifetime technology large scale intermediates arran chemical company pharmaceutical development about about pharmaceutical development pharmaceutical development – early phase pharmaceutical development – early phase overview non-gmp development solubility enhancement potent processing scalability pharmaceutical development – late phase pharmaceutical development – late phase overview quality by design potent processing scalability pharmaceutical drug product development expansion: charnwood facilities charnwood facilities analytical & solid state services analytical & solid state services about analytical & solid state services physical and chemical characterisation method development and validation clinical and commercial analytical support stability testing preformulation preformulation overview pre-clinical package for small molecules formufast™: pre-clinical formulation development enabling salt screen solid state services solid state services overview solid state analysis solid state analysis overview bioclin research laboratories bioclin research laboratories clinical services about about clinical services commercial drug procurement commercial drug procurement overview clinical supply chain management clinical supply chain management overview the physical and digital clinical supply chain technology webez™ pharmacy services blinding of clinical trial supplies overview over-encapsulation inhaler blinding clinical packaging (primary) clinical packaging (primary) overview blistering wallet cards bottling enhanced containment and potent products clinical packaging (secondary) clinical packaging (secondary) overview secondary labelling and kitting of clinical supplies label generation, printing and checking biological products clinical storage & distribution clinical storage & distribution overview distribution global depot network direct-to-patient next gen temperature management overview tempez™ temperature services temperature monitors almac pod™ global distribution qualified person services qualified person services overview qp facilitation program clinical technologies about about clinical technologies interactive response technology (ixrs ® 3) interactive response technology (ixrs ® 3) overview biostatistical consulting reporting data integration clinical integrated services clinical integrated services overview biostatistical services biostatistical services overview art™ – accountability & reconciliation tracking art™ – accountability & reconciliation tracking overview commercial services about about commercial services pharmaceutical product launch & distribution pharmaceutical product launch and distribution overview experience product supply management end-to-end product supply commercial drug product manufacture commercial drug product manufacture overview technology transfer scalability capital projects commercial packaging commercial packaging overview artwork and pack design specialised packaging complex kit assembly pharmaceutical repackaging solutions cbe – 30 filing capital projects dedicated penicillin packaging facilities serialisation serialisation services paediatrics paediatrics commercial storage and distribution commercial storage and distribution overview inventory management & storage import / export support temperature sensitive shipping solutions 3rd party logistics (3pl) menu services general about about us almac history, culture and values company overview video ethical statement leadership core values & vision our history awards almac awards awards archive sir allen mcclay tax strategy: almac approach our locations careers almac careers careers overview graduate careers why choose an apprenticeship at almac? experienced professionals economy & cost of living schools, outreach and undergraduates for parents & students for teachers sloane mcclay award uk and row careers us careers apply
Whois est un protocole qui permet d'accéder aux informations d'enregistrement.Vous pouvez atteindre quand le site Web a été enregistré, quand il va expirer, quelles sont les coordonnées du site avec les informations suivantes. En un mot, il comprend ces informations;
For more information on Whois status codes, please visit https://icann.org/epp
NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.
TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.
The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.
REGISTRAR Network Solutions, LLC.
SERVERS
SERVER com.whois-servers.net
ARGS domain =almacgroup.com
PORT 43
TYPE domain RegrInfo DOMAIN
NAME almacgroup.com
CHANGED 2016-12-29
CREATED 2006-02-27
STATUS clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Nous utilisons des cookies pour personnaliser votre expérience sur notre site. En poursuivant votre navigation, vous acceptez cette utilisation. Apprendre encore plus
almacgroup.com rapport :
Visitez le site